Fulvestrant contains not less than 97.0% and not more than 102.0% of C32H47F5O3S, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

"霖揚"氟亞碸雌二醇
Fulvestrant "GBC"

• 申請商: 霖揚生技製藥股份有限公司
• 適應症: 治療雌激素受體陽性的局部晚期或轉移性乳癌。
• 發證日期: 2021-09-15